167
Views
4
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR Neutropenia and Bone Marrow Failure

Metamizole-Induced Bicytopenia Reversed by G-CSF and IVIG Treatment in a Child

, , , &
Pages 117-119 | Received 22 Oct 2013, Accepted 09 Dec 2013, Published online: 10 Feb 2014

REFERENCES

  • Basak GW, Drozd-Sokołowska J, Wiktor-Jedrzejczak W. Update on the incidence of metamizole sodium-induced blood dyscrasias in Poland. J Int Med Res. 2010;38:1374–1380.
  • Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol. 2002;58:265–274.
  • Ibáñez L, Vidal X, Ballarín E, Laporte JR. Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol. 2005;60:821–829.
  • Yetgin S, Ozyürek E, Aslan D, Cetin M. Metamizole sodium-induced severe aplastic anemia and its recovery with a short-course steroid therapy. Pediatr Hematol Oncol. 2004;21:343–347.
  • Jurczyszyn A, Engel A, Bazan-Socha S, Czepiel J, Biesiada G, Skotnicki AB. Bone marrow suppression with plasma cell leukemia like reaction complicated by macrophage activation syndrome after metamizole overuse. Pol Arch Med Wewn. 2013;123:257–258.
  • Heit WF. Hematologic effects of antipyretic analgesics: Drug-induced agranulocytosis. Am J Med. 1983;75:65–69.
  • Atrah HI, Davidson RJL. Mechanism of action of intravenous immunoglobulin in immune-mediated cytopenias. J Clin Pathol. 1988;41:1249–1255.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.